Keros Therapeutics KROS
NASDAQ KROS
$11.26 +0.08 (+0.72%)
As of: Oct 22, 2026 · 10:06 AM EDT

Keros Therapeutics (KROS) Times Interest Earned (2019 - 2022)

Updated

Keros Therapeutics' Times Interest Earned came in at -114790.00 for FY2022, compared with -14093.25 in FY2021.

Analysis

Keros Therapeutics (KROS) Times Interest Earned (2019 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put Times Interest Earned at -14093.25 in FY2021 and -7776.17 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn -
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn 25.41
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn -
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn -
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 10.28
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn 7.27
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn 5.22
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn -42.08
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn -
10 Keros Therapeutics 222.95 Mn -1.71 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -24,126.00
Dec 31, 2021 -4,866.00
Sep 30, 2021 -20,197.00
Jun 30, 2021 -15,541.00
Mar 31, 2021 -15,769.00
Dec 31, 2020 -13,291.00
Sep 30, 2020 -5,974.00
Jun 30, 2020 -10,914.00
Mar 31, 2020 -5,252.00
Sep 30, 2019 -775.33
Jun 30, 2019 -1,325.50
Mar 31, 2019 -1,429.00
API Access

Keros Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=KROS&period=max&api_key=YOUR_API_KEY